Bristol Myers Squibb (BMY) Moves From Russell Growth Indexes To Value And Defensive

Bristol-Myers Squibb (NYSE:BMY) has been added to the Russell 1000 Value Defensive and Russell 1000 Defensive Indexes. At the ...
Hosted on MSN

Why Bristol Myers Squibb stock isn't nearly as cheap as it looks

Bristol Myers Squibb's stock looks cheap on several key metrics. The company has patent expirations that will be a headwind through 2028. 10 stocks we like better than Bristol Myers Squibb › Bristol ...

Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Bristol Myers Squibb trades at a deep discount, while Johnson & Johnson boasts higher margins and a broader reach. How do their financials and risks stack up?
The Motley Fool

Bristol Myers Squibb's value appeal

It would be understandable if value investors jumped aboard. For dividend investors attracted to the lofty yield, the company's 70% payout ratio is a bit high but not unreasonably so. Still, you ...